Stockscreener 앱 받기
11.25
8.54%
-1.05
시간 외 거래:
11.05
-0.20
-1.78%
전일 마감가:
$12.30
열려 있는:
$12.12
하루 거래량:
648.37K
Relative Volume:
2.42
시가총액:
$137.87M
수익:
$1.54M
순이익/손실:
$-38.70M
주가수익비율:
-2.409
EPS:
-4.67
순현금흐름:
$-36.86M
1주 성능:
-34.29%
1개월 성능:
-24.14%
6개월 성능:
+44.42%
1년 성능:
-38.56%
1일 변동 폭
$11.22
$12.17
1주일 범위
$11.22
$17.75
52주 변동 폭
$4.64
$20.77
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
명칭
Corbus Pharmaceuticals Holdings Inc
전화
617-963-0103
주소
500 RIVER RIDGE DRIVE, NORWOOD, MA
CRBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
11.25 | 150.74M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2025-02-28 | 개시 | William Blair | Outperform |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 개시 | Wedbush | Outperform |
| 2024-07-22 | 재개 | H.C. Wainwright | Buy |
| 2024-06-26 | 개시 | B. Riley Securities | Buy |
| 2024-06-03 | 재확인 | Oppenheimer | Outperform |
| 2024-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-07 | 개시 | ROTH Capital | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-03-26 | 개시 | Nomura | Buy |
| 2019-04-05 | 개시 | Jefferies | Buy |
| 2019-03-20 | 개시 | Oppenheimer | Outperform |
| 2019-01-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-12-26 | 개시 | H.C. Wainwright | Buy |
| 2018-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2018-10-24 | 개시 | B. Riley FBR | Buy |
| 2018-01-19 | 개시 | Raymond James | Outperform |
| 2017-12-14 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-11-08 | 재확인 | Noble Financial | Buy |
| 2017-09-29 | 재개 | Noble Financial | Buy |
| 2017-03-30 | 재확인 | Cantor Fitzgerald | Overweight |
| 2016-11-15 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-11-11 | 재확인 | Noble Financial | Buy |
모두보기
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidateJuly 2025 Action & AI Enhanced Trading Signals - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock sustain market leadershipPortfolio Update Summary & Real-Time Volume Analysis - newser.com
What analyst consensus says on Corbus Pharmaceuticals Holdings Inc. stockMarket Trend Review & Consistent Profit Trading Strategies - newser.com
Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.2025 Market Sentiment & Fast Moving Market Watchlists - newser.com
Short interest data insights for Corbus Pharmaceuticals Holdings Inc.Market Growth Report & Fast Moving Stock Trade Plans - newser.com
Published on: 2025-11-04 00:52:02 - newser.com
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. lossesWeekly Trend Report & Verified Technical Trade Signals - newser.com
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.71 a shareEarnings Preview - TradingView
Corbus Pharmaceuticals Announces $70.5M Public Offering - TipRanks
Form 424B5 Corbus Pharmaceuticals - StreetInsider
Is Corbus Pharmaceuticals Holdings Inc. stock a contrarian buyPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Published on: 2025-11-03 05:13:38 - newser.com
Quantitative breakdown of Corbus Pharmaceuticals Holdings Inc. recent move2025 Top Gainers & High Yield Stock Recommendations - newser.com
Understanding Corbus Pharmaceuticals Holdings Inc.’s price movement2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Will breakout in Corbus Pharmaceuticals Holdings Inc. lead to full recoveryJuly 2025 Final Week & Pattern Based Trade Signal System - newser.com
AlphaQuest LLC Has $218,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat
How institutional buying supports Corbus Pharmaceuticals Holdings Inc. stockEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock reach $100 price targetIPO Watch & Low Drawdown Investment Strategies - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsWeekly Profit Analysis & Technical Buy Zone Confirmations - newser.com
How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockOil Prices & Growth Focused Stock Reports - newser.com
Corbus Pharmaceuticals slumps 17%, prices $75M at $13 per share - MSN
Published on: 2025-11-02 11:47:57 - newser.com
Published on: 2025-11-02 07:07:31 - newser.com
Comparing Corbus Pharmaceuticals Holdings Inc. in custom built stock radarsMarket Growth Report & Reliable Entry Point Trade Alerts - newser.com
Published on: 2025-11-01 11:30:29 - newser.com
Published on: 2025-11-01 08:40:29 - newser.com
Corbus Pharmaceuticals provides preliminary Q3 cash estimate in SEC filing By Investing.com - Investing.com Australia
Corbus prices $75 million public offering of common stock By Investing.com - Investing.com Philippines
Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP) - Seeking Alpha
Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com - Investing.com UK
Corbus Pharmaceuticals stock plunges after $75 million public offering - Investing.com
Corbus Pharmaceuticals announces common stock offering By Investing.com - Investing.com Australia
Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Passes Above 50-Day Moving AverageShould You Sell? - MarketBeat
Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Corbus prices $75 million public offering of common stock - Investing.com India
Corbus Pharmaceuticals (CRBP) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Corbus Pharmaceuticals Holdings Inc (CRBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Corbus Pharmaceuticals Holdings Inc 주식 (CRBP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cohen Yuval | Chief Executive Officer |
Oct 27 '25 |
Option Exercise |
4.26 |
8,973 |
38,225 |
147,160 |
| Cohen Yuval | Chief Executive Officer |
Oct 24 '25 |
Sale |
17.01 |
18,660 |
317,407 |
138,187 |
| Cohen Yuval | Chief Executive Officer |
Oct 27 '25 |
Sale |
17.14 |
8,973 |
153,797 |
138,187 |
| Moran Sean F. | Chief Financial Officer |
Oct 24 '25 |
Option Exercise |
4.26 |
12,981 |
55,299 |
86,294 |
| Moran Sean F. | Chief Financial Officer |
Oct 24 '25 |
Sale |
17.02 |
12,981 |
220,937 |
73,313 |
1.45%
0.86%
자본화:
|
볼륨(24시간):